Lina Matta
Overview
Explore the profile of Lina Matta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fisher N, Fera L, Dunning J, Desai S, Matta L, Liquori V, et al.
Clin Cardiol
. 2018 Dec;
42(2):285-291.
PMID: 30582181
Background: Hypertension remains poorly controlled on the population level. National rates of control, even when defined leniently by BP < 140/90 mm Hg, are only ~50%. As growing healthcare costs...
12.
Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, et al.
Am J Health Syst Pharm
. 2018 Jul;
75(17 Supplement 3):S63-S71.
PMID: 29976830
Purpose: The utility of a transitions-of-care (TOC) pharmacist intervention focused on improving the quality and safety of the medication process for high-risk cardiovascular patients was evaluated. Methods: A quality-improvement initiative...
13.
Cook B, Carter D, Dellorfano H, Matta L
Crit Pathw Cardiol
. 2017 Nov;
16(4):158-160.
PMID: 29135624
Potassium supplementation can be administered intravenously or orally with either immediate release or sustained release formulations. Sustained release potassium chloride allows for delayed absorption and peak effects. In the inpatient...
14.
Buckley L, Seoane-Vazquez E, Cheng J, Aldemerdash A, Cooper I, Matta L, et al.
Am J Cardiol
. 2016 Oct;
118(9):1350-1355.
PMID: 27772698
Innovative treatment strategies for decompensated heart failure (HF) are required to achieve cost savings and improvements in outcomes. We developed a decision analytic model from a hospital perspective to compare...
15.
Buckley L, Carter D, Matta L, Cheng J, Stevens C, Belenkiy R, et al.
JACC Heart Fail
. 2015 Dec;
4(1):1-8.
PMID: 26656139
Objectives: This study sought to evaluate the effectiveness of intravenous (IV) diuretic treatment for volume management in heart failure (HF). Background: Limited data exist regarding IV diuretics for the outpatient...
16.
Gilmore J, Adams C, Blum R, Fanikos J, Anne Hirning B, Matta L
Am J Hematol
. 2015 Apr;
90(8):E143-5.
PMID: 25913754
No abstract available.
17.
Sylvester K, Rocchio M, Belisle C, Matta L, Goralnick E
Ann Pharmacother
. 2014 May;
48(8):1082-1085.
PMID: 24842858
Objective: Effective crisis response requires multidisciplinary communication and rapid action. Our goals are to highlight the experience of a pharmacy department's response to the 2013 Boston Marathon bombing, to discuss...
18.
Aday A, Dellorfano H, Hirning B, Matta L, OBrien M, Scirica B, et al.
Eur Heart J Acute Cardiovasc Care
. 2013 Dec;
2(4):299-305.
PMID: 24338288
Background: Intravenous sedation and analgesia are important therapies during mechanical ventilation (MV). However, daily interruption of these medications is associated with improved outcomes in mechanically ventilated patients. We tested a...
19.
Sylvester K, Fanikos J, Anger K, Matta L, Southard R, Beik N, et al.
Pharmacotherapy
. 2013 Jul;
33(11):1191-8.
PMID: 23813781
Study Objective: To evaluate whether using an immunoglobulin G (IgG)-specific platelet factor 4 (PF4) test reduces the rate of positive PF4 results and has an impact on prescribing practices of...
20.
Yeh Y, McDonnell A, Klinger E, Fowler B, Matta L, Voit D, et al.
J Oncol Pharm Pract
. 2010 May;
17(3):179-85.
PMID: 20452991
Objective: To analyze the differences between ondansetron and palonosetron in healthcare resource use (i.e., inpatient/ outpatient encounters) among patients receiving intraperitoneal cisplatin. Method: A medical record review was performed. Intraperitoneal...